# Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors

> **NCT01543763** · PHASE1 · COMPLETED · sponsor: **Pamela Munster** · enrollment: 90 (actual)

## Conditions studied

- Metastatic Solid Tumors

## Interventions

- **DRUG:** PZP115891, PCI-24781

## Key facts

- **NCT ID:** NCT01543763
- **Lead sponsor:** Pamela Munster
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06-25
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-03-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01543763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01543763, "Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01543763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*